{"org_id": "02600079", "org_name_cn": "人福医药集团股份公司", "org_short_name_cn": "人福医药", "org_name_en": "Humanwell Healthcare (Group) Co.,Ltd.", "org_short_name_en": "HWHG", "main_operation_business": "药品的研发、生产和销售。", "operating_scope": "　　药品研发；生物技术研发；化工产品（化学危险品除外）的研发、销售；技术开发、技术转让及技术服务；货物进出口、技术进出口、代理进出口（不含国家禁止或限制进出口的货物或技术）；对医药产业、医疗机构的投资；对医药产业、医疗机构的管理；互联网药品、医疗器械信息服务；组织“三来一补”业务。（涉及许可经营项目，应取得相关部门许可后方可经营）", "district_encode": "420111", "org_cn_introduction": "人福医药集团股份公司的主营业务为药品的研发、生产和销售。公司主要产品为药品、医疗器械、安全套。公司坚持实施国际化战略，面向全球医药市场进行产业布局，海外业务现已覆盖了欧美成熟市场以及南美、东南亚、中亚、西非、东非等新兴市场。", "legal_representative": "李杰", "general_manager": "邓霞飞", "secretary": "李前伦", "established_date": 733420800000, "reg_asset": 1633071908.0, "staff_num": 15042, "telephone": "86-27-87597232", "postcode": "430075", "fax": "86-27-87596393", "email": "renfu.pr@renfu.com.cn;wuwenjing@renfu.com.cn", "org_website": "www.humanwell.com.cn", "reg_address_cn": "湖北省武汉市洪山区东湖高新区高新大道666号", "reg_address_en": "", "office_address_cn": "湖北省武汉市洪山区东湖高新区高新大道666号", "office_address_en": "", "currency_encode": "019001", "currency": "CNY", "listed_date": 865526400000, "provincial_name": "湖北省", "actual_controller": "艾路明 (8.45%)", "classi_name": "民营企业", "pre_name_cn": "武汉人福医药集团股份有限公司", "chairman": "李杰", "executives_nums": 21, "actual_issue_vol": 20000000.0, "issue_price": 5.22, "actual_rc_net_amt": 99018000.0, "pe_after_issuing": 15.0, "online_success_rate_of_issue": 1.1705, "affiliate_industry": {"ind_code": "BK0040", "ind_name": "化学制药"}}